product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Rabbit anti p63 (C-Terminal)
catalog :
AHP1815
quantity :
0.1 mg
price :
526 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human, mouse
application :
western blot, ELISA
more info or order :
Bio-Rad product webpage
product information
Entity Type :
Polyclonal Antibody
Entity Category :
Antibodies
Region :
(C-TERMINAL)
ProductCode :
AHP1815
Description :
Rabbit anti p63 (C-Terminal)
Specificity :
p63
TargetSpecies :
Human
Host :
Rabbit
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
WB,E
ApplicationTypes :
Western Blotting,ELISA
Cross Reactivities :
Mouse
Quantity :
0.1 mg
Quantity Value :
0.1
Quantity Type :
mg
GO Accessions :
GO:0000122,GO:0005515,GO:0001501,GO:0001736,GO:0002053,GO:0002064,GO:0002347,GO:0003682,GO:0003684,GO:0005634,GO:0006916,GO:0007219,GO:0007499,GO:0008270,GO:0009954,GO:0010259,GO:0030216,GO:0030308,GO:0030326,GO:0030859,GO:0031069,GO:0035121,GO:0042475,GO:0042771,GO:0043565,GO:0043589,GO:0043616,GO:0045617,GO:0045944,GO:0048485,GO:0048745,GO:0048807,GO:0051402,GO:0060157,GO:0060197,GO:0060513,GO:0060529
GOTerms :
negative regulation of transcription from RNA polymerase II promoter,protein binding,skeletal system development,establishment of planar polarity,positive regulation of mesenchymal cell proliferation,epithelial cell development,response to tumor cell,chromatin binding,damaged DNA binding,nucleus,anti-apoptosis,Notch signaling pathway,ectoderm and mesoderm interaction,zinc ion binding,proximal/distal pattern formation,multicellular organismal aging,keratinocyte differentiation,negative regulation of cell growth,embryonic limb morphogenesis,polarized epithelial cell differentiation,hair follicle morphogenesis,tail morphogenesis,odontogenesis of dentine-containing tooth,DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis,sequence-specific DNA binding,skin morphogenesis,keratinocyte proliferation,negative regulation of keratinocyte differentiation,positive regulation of transcription from RNA polymerase II promoter,sympathetic nervous system development,smooth muscle tissue development,female genitalia morphogenesis,neuron apoptosis,urinary bladder development,cloacal septation,prostatic bud formation,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development
Uniprot Accessions :
Q9H3D4,O88898
Gene :
Trp63,TP63
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=22061, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=8626
Published Synonyms :
p73L
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 1.0mg/ml.
Product Form :
Purified IgG - liquid
PriceGBP :
377
PriceEUR :
526
PriceUSD :
526 USD
PriceCHF :
572
PriceSEK :
5734
PriceNOK :
5762
PriceDKK :
3922
more info or order :
Bio-Rad product webpage
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.